The CPDRN was administered by the Peking Union Medical College Hospital (PUMCH) in 2015 and is accessible on the internet (www.cpdrn.cn). As of February 2018, 32 provincial and national hospitals throughout China, which are all members of the Chinese Pituitary Adenoma Collaboration Group, have been enlisted. These are large pituitary centers performing over 100 pituitary operations annually.
The system is composed of software specifically designed based on the B/S structure and a database based on SQL Server 2012 software; the system can thereby support the automated data integration from third-party systems, including hospital information systems (HIS), laboratory information systems, radiology information systems, and electronic patient records. Case report forms (CRFs) were designed by the China Pituitary Adenoma Specialist Council.
The database permits patients who have undergone pituitary surgery and have been pathologically diagnosed since 2015 to be entered prospectively; the database also allows patient data to be entered retrospectively for cases diagnosed before 2015, via electronic medical records. Fourteen categories of pituitary disease were included in the CPDRN database. Pituitary adenoma was the most common diagnosis (14,193, 98.47%), among which nonfunctioning pituitary adenoma accounted for the largest proportion. Prolactin-secreting adenomas accounted for 15.02% of the total, which is lower than previously reported (44-59%). The initial treatment of prolactin-secreting adenomas was dopaminergic agonists, rather than neurosurgery. [6] Adrenocorticotropic hormone-secreting adenomas accounted for approximately 12.28% of all pituitary adenomas in the CPDRN, which is higher than the 1-7% reported in Finland; this outcome is related to PUMCH's expertise in Cushing's disease, which affects patients' choice of hospital. [6] Craniopharyngioma (95, 0.66%), Rathke's clef cysts (74, 0.51%), hypophysitis (6, 0.04%), germinoma (3, 0.02%), pituitary carcinoma (44, 0.31%), and diabetes insipidus (1, 0.01%) were in the minority diagnoses, while no cases of histiocytosis have been entered in the registry [ Table 1 ].
The registry is multicenter based instead of population based, and epidemiological data, including incidence and prevalence rates, cannot be obtained. Selection bias arises because those who volunteer to participate in a registry or who attend a specialty clinic that provides registry data may not be representative of the true population. Analytic techniques may be required to account for biases or for the complex sampling schemes encountered when using registry data. Other discrepancies come from variations in data quality acquired from the different centers. A total of 11,444 patients have no follow-up records, which points out insufficiencies in data collection. Requiring a follow-up plan being entered into the database after uploading the initial treatment is a promising solution. With a timespan from 1978 to 2018, the database contains changes not only in diagnostic criteria but also in diagnostic tools and all other aspects of medical care. Thus, we collected clinical data based on well-defined CRFs, including laboratory tests, imaging findings, and pathologic results, to make it possible to include cases with the original evidence.
In conclusion, as the first nationwide multicenter pituitary disease registry database, the CPDRN has effectively formed a network among Chinese centers to support the excellent medical treatment of pituitary disease; these centers now can serve the entire population and function at terminals or webnodes to recruit further neurosurgery and endocrinology centers from their respective parts of China.
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